# \[e-drug\] Prescrire maintains its complaints against EMA maladministration

**URL:** <https://talk.edrugplus.org/t/e-drug-prescrire-maintains-its-complaints-against-ema-maladministration/35324>\
**Category:** e-drug\
**Created:** [April 6, 2011, 12:24pm UTC](https://talk.edrugplus.org/t/e-drug-prescrire-maintains-its-complaints-against-ema-maladministration/35324 "2011-04-06T12:24:33Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Christophe\_KOPP](https://avatars.discourse-cdn.com/v4/letter/c/a9adbd/32.png) [@Christophe\_KOPP](https://talk.edrugplus.org/u/Christophe_KOPP)\
**Post date:** [April 6, 2011, 12:24pm UTC](https://talk.edrugplus.org/t/e-drug-prescrire-maintains-its-complaints-against-ema-maladministration/35324/1 "2011-04-06T12:24:33Z")

</div>

E-DRUG: Prescrire maintains its complaints against EMA maladministration  
------------------------------------------------------------

E-Druggers

Prescrire filed 5 complaints with the European Ombudsman on 30 August 2010, citing repeated refusals by the European Medicines Agency (EMA) to provide documents, in particular concerning drugs with a negative risk-benefit balance. After EMA's response in January 2011, Prescrire has decided to maintain all 5 of its complaints, which involve rimonabant, dextropropoxyphene, topical ketoprofen, access to PSURs and packaging materials.

Full details can be found here: [http://english.prescrire.org/en/81/168/46876/0/NewsDetails.aspx](http://english.prescrire.org/en/81/168/46876/0/NewsDetails.aspx)

Christophe Kopp  
Prescrire editorial team  
Website: english.prescrire.org  
email: ckopp@prescrire.org